No Data
Trump wants to impose tariffs on Pharmaceuticals: Pharmaceutical companies are busy stockpiling, and the import volume in the USA surged in March.
① The volume of Pharmaceutical imports in the USA surged in March, as pharmaceutical companies stockpiled products in anticipation of potential tariffs; ② A report released by the US Department of Commerce on Tuesday showed that the total value of Pharmaceutical imports in March exceeded 50 billion USD, equivalent to 20% of the total Pharmaceutical imports for the entire year of 2024.
The Pacific Securities: The Sector's profits improved significantly in Q1, and the pharmaceutical industry is expected to see a rapid increase in concentration.
The trend of increasing concentration in the pharmaceutical industry and the strong becoming stronger is expected to continue to strengthen.
JACOBSON PHARMA (02633.HK) subscribes to 94 million shares of TYCOON GROUP Holdings.
On April 29, Glonghui announced that JACOBSON PHARMA (02633.HK) entered into a subscription agreement with TYCOON GROUP, whereby the subscriber, Jacobson Group Treasury Limited (a wholly owned subsidiary of the company), conditionally agrees to subscribe for a total of 94 million subscription shares at a subscription price of HKD 0.500 per share, subject to the terms and conditions set forth in the subscription agreement.
Express News | Jacobson Pharma Corporation Ltd - to Subscribe Shares in Tycoon Group
The Trump administration plans to impose tariffs on imported Pharmaceuticals, and the U.S. Pharmaceutical Industry warns that it may increase drug costs.
A report commissioned by a trade organization in the USA Pharmaceutical Industry indicates that if the USA imposes a 25% tariff on imported Pharmaceuticals, it could increase the annual Pharmaceutical costs in the USA by nearly 51 billion dollars and raise drug prices by up to 12.9%.
Accelerating recovery? In March, domestic Innovative Drugs investment and financing increased by about 50% year-on-year, and the Hong Kong Stock pharmaceutical Sector collectively surged.
① In March, domestic investment and financing for Innovative Drugs increased by approximately fifty percent year-on-year, how significant is the Bullish impact? ② The Hong Kong stock market's pharmaceutical Sector rose collectively, which stocks are attracting market attention?
Jacobson Pharma's (HKG:2633) Profits Appear To Have Quality Issues